Search tips
Search criteria 


Logo of jnmaLink to Publisher's site
J Natl Med Assoc. 2002 November; 94(11): 963–970.
PMCID: PMC2594186

Prostate cancer education in the Washington, DC, area.


Pharmacists are key members of the healthcare team, especially in minority and urban communities. This study was developed to assess pharmacists' ability and willingness to counsel the public on prostate cancer in the community pharmacy setting. A mail survey was sent to all 192 community pharmacies in Washington, DC, and Prince George's County, Maryland. A total of 90 pharmacists responded to the questionnaire, providing a 46.9% response rate. One third of the pharmacists indicated a willingness to participate in a prostate cancer training program. Perceived benefits and perceived barriers were each measured through five questionnaire items using Likert-style statements with responses ranging from "strongly agree" to "strongly disagree." The most significant predictor of perceived benefits of providing prostate cancer information was gender; male pharmacists perceived greater benefits for providing prostate cancer information than female pharmacists. Similarly, black pharmacists perceived greater benefits of providing prostate cancer information to their patients than non-black pharmacists. Also, pharmacists in stores that offered disease state management programs had a significantly lower perceived benefit of providing prostate cancer information. These findings indicate that gender and race may play a role in health promotion in health disparities. There were no significant barriers to providing prostate cancer information. Thus, many pharmacists are willing to participate in health education on prostate cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Barber KR, Shaw R, Folts M, Taylor DK, Ryan A, Hughes M, Scott V, Abbott RR. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program. J Community Health. 1998 Dec;23(6):441–451. [PubMed]
  • Abbott RR, Taylor DK, Barber K. A comparison of prostate knowledge of African-American and Caucasian men: changes from prescreening baseline to postintervention. Cancer J Sci Am. 1998 May-Jun;4(3):175–177. [PubMed]
  • Weinrich SP, Weinrich M, Mettlin C, Reynolds WA, Jr, Wofford JE. Urinary symptoms as a predictor for participation in prostate cancer screening among African American men. Prostate. 1998 Dec 1;37(4):215–222. [PubMed]
  • Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001 Mar 7;93(5):388–395. [PubMed]
  • Cookson MM. Prostate cancer: screening and early detection. Cancer Control. 2001 Mar-Apr;8(2):133–140. [PubMed]
  • Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995 Jul;46(1):71–77. [PubMed]
  • Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999 Aug 18;91(16):1409–1415. [PubMed]
  • Ashford AR, Albert SM, Hoke G, Cushman LF, Miller DS, Bassett M. Prostate carcinoma knowledge, attitudes, and screening behavior among African-American men in Central Harlem, New York City. Cancer. 2001 Jan 1;91(1):164–172. [PubMed]
  • Myers RE, Chodak GW, Wolf TA, Burgh DY, McGrory GT, Marcus SM, Diehl JA, Williams M. Adherence by African American men to prostate cancer education and early detection. Cancer. 1999 Jul 1;86(1):88–104. [PubMed]
  • Powell IJ, Heilbrun L, Littrup PL, Franklin A, Parzuchowski J, Gelfand D, Sakr W. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol. 1997 Jul;158(1):146–149. [PubMed]
  • Cotter Michael P, Gern Robert W, Ho Gloria Y F, Chang Richard Y, Burk Robert D. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 2002 Mar 1;50(4):216–221. [PubMed]
  • Etzioni Ruth, Berry Kristin M, Legler Julie M, Shaw Pamela. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology. 2002 Feb;59(2):251–255. [PubMed]
  • Mayer JA, Eckhardt L, Stepanski BM, Sallis JF, Elder JP, Slymen DJ, Creech L, Graf G, Palmer RC, Rosenberg C, et al. Promoting skin cancer prevention counseling by pharmacists. Am J Public Health. 1998 Jul;88(7):1096–1099. [PubMed]
  • Souvignier ST, Mayer JA, Eckhardt L. Educating the public about skin cancer prevention: a role for pharmacists. J Clin Pharm Ther. 1996 Dec;21(6):399–406. [PubMed]
  • Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984 Spring;11(1):1–47. [PubMed]
  • O'Malley AS, Kerner JF, Johnson L. Are we getting the message out to all? Health information sources and ethnicity. Am J Prev Med. 1999 Oct;17(3):198–202. [PubMed]
  • Giles JT, Kennedy DT, Dunn EC, Wallace WL, Meadows SL, Cafiero AC. Results of a community pharmacy-based breast cancer risk-assessment and education program. Pharmacotherapy. 2001 Feb;21(2):243–253. [PubMed]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association